CA
NZ
UK
AU
IND
US
Vaxart Inc. (OTC: VXRT) shareholders have cast votes on several important items, notably the selection of directors and the approval of executive compensation arrangements. According to the filing, proxies representing approximately 45.7% of outstanding shares were submitted. This level of participation underscores the relevance …
NKGen Biotech has completed an amendment to its loan agreement, reinforcing its financial foundation to support ongoing and future initiatives. This adjustment reflects the company’s efforts to optimize its capital structure while maintaining operational flexibility in a competitive biotech environment. The revised terms provide …
Northwest Biotherapeutics has firmly rejected claims that UK regulators rejected its application for DCVax-L, an investigational therapy for glioblastoma. Following this clarification, the stock showed brief volatility before returning to levels near recent lows.
Novartis (Basel) stands at a key moment as three key drug studies approach their readouts later this year. The programs, one targeting a cardiovascular condition, another addressing multiple sclerosis, and a third focused on a rare genetic disorder, have the collective potential to generate …
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) has announced a retention program targeting its senior leadership team, including the Chief Executive Officer, as the company prepares for a series of strategic developments. The program is structured to reinforce leadership continuity during a period of anticipated catalysts …
NanoViricides has established a flexible financing mechanism through an at-market stock sales agreement, enabling the company to issue shares as needed. The arrangement, finalized with D. Boral Capital LLC, allows the antiviral drug developer to access capital markets without the constraints of a fixed …
JPMorgan Chase Financial Company LLC priced $368 million in structured notes on July 16, 2026, designed to provide leveraged exposure to the performance of the iShares MSCI EAFE ETF and the EURO STOXX 50 Index. The notes, fully guaranteed by JPMorgan Chase & Co., …
The settlement, disclosed in a regulatory filing, closes a probe by the U.S. Department of Justice and the Office of Inspector General without the company admitting wrongdoing. EyePoint will also enter a Corporate Integrity Agreement with the Department of Health and Human Services, mandating …
Hims & Hers Health has announced the resignation of its Chief Accounting Officer, the latest in a series of leadership changes at the telehealth provider. The departure follows a series of similar disclosures and comes as the company navigates a period of steady but …
IBio has announced that its upcoming annual shareholder gathering will take place in mid‑October, prompting a revision of the deadlines for shareholder proposals as the company’s shares continue to face downward pressure. The meeting will be held on a date set for the middle …
Please wait processing your request...